Alerts will be sent to your verified email
Verify EmailPOLYMED
|
Poly Medicure
|
TTK Healthcare
|
3B Blackbio Dx
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Unclassified
|
|||
|
R&D as a % of Total Sales
|
1.47 % | 0.02 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
14.36 % | 19.91 % | 30.57 % |
|
5yr average Equity Multiplier
|
1.28 | 1.3 | 1.21 |
|
5yr Average Asset Turnover Ratio
|
0.64 | 0.72 | 0.5 |
|
5yr Avg Net Profit Margin
|
17.65 % | 24.27 % | 44.97 % |
|
Price to Book
|
5.43 | 1.25 | 3.16 |
|
P/E
|
52.35 | 21.26 | 17.5 |
|
5yr Avg Cash Conversion Cycle
|
48.25 Days | -3.67 Days | 128.05 Days |
|
Inventory Days
|
57.3 Days | 43.41 Days | 30.75 Days |
|
Days Receivable
|
67.43 Days | 41.32 Days | 137.66 Days |
|
Days Payable
|
95.26 Days | 110.17 Days | 46.71 Days |
|
5yr Average Interest Coverage Ratio
|
26.49 | 23.15 | 440.19 |
|
5yr Avg ROCE
|
18.85 % | 8.03 % | 37.21 % |
|
5yr Avg Operating Profit Margin
|
25.65 % | 4.06 % | 51.13 % |
|
5 yr average Debt to Equity
|
0.11 | 0.03 | 0.01 |
|
5yr CAGR Net Profit
|
20.03 % | 9.57 % | -15.98 % |
|
5yr Average Return on Assets
|
11.2 % | 15.8 % | 23.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
62.42 % | 74.56 % | 40.95 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
9.11 % | 0.0 | 2.52 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
5.82 % | -2.98 % | 0.0 |
|
Poly Medicure
|
TTK Healthcare
|
3B Blackbio Dx
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|